CD45+CD326+ Cells are predictive of poor prognosis in Non-Small Cell Lung Cancer patients.
CONCLUSIONS: In conclusion, varying percentages of CD45/CD326 DPC exist in both solid cancer tissue and malignant pleural effusion in patients with NSCLC. This CD45/CD326 doubly-positive subpopulation can be an important key to clinical management of NSCLC patients.
PMID: 31383733 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Ishizawa K, Yamanaka M, Saiki Y, Miyauchi E, Fukushige S, Akaishi T, Asao A, Mimori T, Saito R, Tojo Y, Yamashita R, Abe M, Sakurada A, Pham NA, Li M, Okada Y, Ishii T, Ishii N, Kobayashi S, Nagasaki M, Ichinose M, Tsao MS, Horii A Tags: Clin Cancer Res Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Study